14169911000001108: Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual medicinal product\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Bicalutamide\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1864581000001112 Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1864591000001114 Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Is a	Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Has active ingredient	Bicalutamide	false	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Has specific active ingredient	Bicalutamide	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets	Is pack of	False	Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets	Has AMP	True	Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1864581000001112	Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1864591000001114	Bicalutamide 50mg tablets (Kent Pharma (UK) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module